AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 289: F531-F535, 2005. First published May 10, 2005; doi:10.1152/ajprenal.00125.2005
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/F531    most recent
00125.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pech, V.
Right arrow Articles by Sands, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pech, V.
Right arrow Articles by Sands, J. M.

Vasopressin increases urea permeability in the initial IMCD from diabetic rats

Vladimir Pech, Janet D. Klein, Shelley D. Kozlowski, Susan M. Wall, and Jeff M. Sands

Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

Submitted 30 March 2005 ; accepted in final form 7 May 2005

In normal rats, vasopressin and hyperosmolality enhance urea permeability (Purea) in the terminal, but not in the initial inner medullary collecting duct (IMCD), a process thought to occur through the UT-A1 urea transporter. In the terminal IMCD, UT-A1 is detected as 97- and 117-kDa glycoproteins. However, in the initial IMCD, only the 97-kDa form is detected. During streptozotocin-induced diabetes mellitus, UT-A1 protein abundance is increased, and the 117-kDa UT-A1 glycoprotein appears in the initial IMCD. We hypothesize that the 117-kDa glycoprotein mediates the vasopressin- and osmolality-induced changes in Purea. Thus, in the present study, we measured Purea in in vitro perfused initial IMCDs from diabetic rats by imposing a 5 mM bath-to-lumen urea gradient without any osmotic gradient. Basal Purea was similar in control vs. diabetic rats (3 ± 1 vs. 5 ± 1 x 10–5 cm/s, n = 4, P = not significant). Vasopressin (10 nM) significantly increased Purea to 16 ± 5 x 10–5 cm/s (n = 4, P < 0.05) in diabetic but not in control rats. Forskolin (10 µM, adenylyl cyclase activator) also significantly increased Purea in diabetic rats. In contrast, increasing osmolality to 690 mosmol/kgH2O did not change Purea in diabetic rats. We conclude that initial IMCDs from diabetic rats have vasopressin- and forskolin-, but not hyperosmolality-stimulated Purea. The appearance of vasopressin-stimulated Purea in initial IMCDs correlates with an increase in UT-A1 protein abundance and the appearance of the 117-kDa UT-A1 glycoprotein in this region during diabetes. This suggests that the 117-kDa UT-A1 glycoprotein is necessary for vasopressin-stimulated urea transport.

diabetes mellitus; inner medullary collecting duct; hyperosmolality



Address for reprint requests and other correspondence: V. Pech, Emory Univ. School of Medicine, Renal Division, 1639 Pierce Dr., NE, WMB Rm. 338, Atlanta, GA 30322 (e-mail: vpech{at}emory.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Blount, J. M. Sands, K. J. Kent, T. D. Smith, S. R. Price, and J. D. Klein
Candesartan augments compensatory changes in medullary transport proteins in the diabetic rat kidney
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1448 - F1452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.